ANI Pharmaceuticals Announces Approval and Launch of Oxycodone Hydrochloride Oral Solution, 100 mg/5mL

BAUDETTE, Minn., Sept. 1, 2017 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration ("FDA") of its Abbrev... Biopharmaceuticals, Generics, FDA, Product Launch ANI Pharmaceuticals, Oxycodone
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news